In particular, a fecal DNA panel consisted of 21 mutations in KRAS, adenomatous polyposis coli and p53 tumor-suppressor genes showed a high sensitivity for detection of CRC compared to fecal immunochemistry and occult blood testing [364]. This evidence concerns the gene KRAS and colorectal carcinoma.